 DarioHealth Corp. Nasdaq: DRIO, a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel. The company received aggregate gross proceeds of approximately 28.6 million, before deducting placement agent fees and other offering expenses. 